NP, Nurse Practitioner / Pa, Physician Assistant - Hematology / Oncology (Longview)

Description

🩸 Job Summary

We are seeking an experienced Hematology / Oncology Nurse Practitioner or Physician Assistant to join our team in Longview, TX . This role will begin in our established oncology clinic, helping to build and grow our oncology service line ahead of the opening of our new, state-of-the-art Cancer Center in October 2026 .

🩺 Key Responsibilities

Provide comprehensive care for hematology and oncology patients in an outpatient clinic setting

Manage follow-up visits, monitor treatment progress, and adjust care plans as appropriate

Collaborate closely with oncologists, nursing staff, and other members of the multidisciplinary team

Educate patients and families on diagnosis, treatment options, side effects, and ongoing care

Maintain accurate documentation within the EMR and ensure continuity of care

Support the growth and development of the oncology program as patient volume increases

Qualifications

Current Texas license as a Nurse Practitioner or Physician Assistant

National board certification (AANP, ANCC, or NCCPA)

Oncology Certified (AOCN) through Oncology Nursing Society

Previous experience in hematology / oncology required

Strong communication, clinical, and organizational skills

Commitment to building a long-term practice and serving the community

🕒 Schedule & Compensation

Full-time, MondayFriday schedule (8 : 00 AM 5 : 00 PM)

Competitive salary, commensurate with experience

Comprehensive benefits package including health, dental, and vision insurance, malpractice coverage, PTO, CME allowance, and 403(b) retirement plan with employer match

🌟 Why Longview?

Located in the heart of East Texas, Longview offers a welcoming community, affordable living, excellent schools, and easy access to both metropolitan areas and outdoor recreation.

Apply Today

Join our mission-driven team and play a key role in shaping the future of cancer care in Longview as we prepare for our new Cancer Center opening in 2026.